These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9417860)

  • 1. The tumor suppressor protein p16INK4a.
    Serrano M
    Exp Cell Res; 1997 Nov; 237(1):7-13. PubMed ID: 9417860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle control and cancer.
    Sherr CJ
    Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
    [No Abstract]   [Full Text] [Related]  

  • 3. The Pezcoller lecture: cancer cell cycles revisited.
    Sherr CJ
    Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
    Shapiro GI; Edwards CD; Rollins BJ
    Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alternative protein p19ARF: a genuine tumor suppressor gene].
    Larsen CJ
    Bull Cancer; 1998 Apr; 85(4):304-6. PubMed ID: 9752293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
    Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence.
    Takahashi A; Ohtani N; Yamakoshi K; Iida S; Tahara H; Nakayama K; Nakayama KI; Ide T; Saya H; Hara E
    Nat Cell Biol; 2006 Nov; 8(11):1291-7. PubMed ID: 17028578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell lines.
    Agiostratidou G; Derventzi A; Gonos ES
    In Vivo; 2001; 15(5):443-6. PubMed ID: 11695244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F; Djakiew D
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16(MTS-1/CDKN2/INK4a) in cancer progression.
    Rocco JW; Sidransky D
    Exp Cell Res; 2001 Mar; 264(1):42-55. PubMed ID: 11237522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
    Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F
    J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
    Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The retinoblastoma protein pathway in cell cycle control and cancer.
    Bartek J; Bartkova J; Lukas J
    Exp Cell Res; 1997 Nov; 237(1):1-6. PubMed ID: 9417859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16INK4a modulates p53 in primary human mammary epithelial cells.
    Zhang J; Pickering CR; Holst CR; Gauthier ML; Tlsty TD
    Cancer Res; 2006 Nov; 66(21):10325-31. PubMed ID: 17079452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.